Synonyms
phenytoin;5,5-DIPHENYLHYDANTOIN;57-41-0;Diphenylhydantoin;Dilantin;5,5-diphenylimidazolidine-2,4-dione;Phenytoine;Zentropil;Epamin;Lepitoin;Dihydantoin;Aleviatin;Dilabid;Diphantoin;Diphenylan;Diphedan;Fenylepsin;Phentytoin;Sodanton;Difenin;Dihycon;Lehydan;Diphenylhydatanoin;Dantoinal;Di-Hydan;Dilantine;Dillantin;Diphenine;Diphentyn;Ditoinate;Elepsindon;Epilantin;Fenitoina;Fenytoine;Hidantilo;Hidantina;Hidantomin;Hydantoinal;Kessodanten;Phanantin;Phanatine;Phenatoine;Sodantoin;Sylantoic;Thilophenyl;Zentronal;Auranile;Dantinal;Dantoine;Difetoin;Difhydan;Dintoin;Dintoina;Diphedal;Diphenin;Enkelfel;Epifenyl;Epihydan;Fentoin;Hidantal;Hydantal;Idantoil;Idantoin;Labopal;Phentoin;Ritmenal;Saceril;Sanepil;Silantin;Solantin;Danten;Denyl;Epelin;Epinat;Epised;Eptal;Hidan;Lepsin;Oxylan;Ekko;Ictalis simple;Toin unicelles;Dilantin acid;Dantoinal klinos;Om-Hydantoine;Di-Phetine;Epdantoine simple;Hidantina vitoria;Gerot-epilan-D;Epilan-D;Neosidantoina;Comitoina;Hidantina senosian;Hydantol;Minetoin;Novantoina;Causoin;Convul;Di-Lan;Ekko capsules;Neos-Hidantoina;2,4-Imidazolidinedione, 5,5-diphenyl-;Om hidantoina simple;TOIN;Phenhydanin;Phenytex;Phenytoinum;Sinergina;Sodanthon;Iphenylhydantoin;Phenytoin-Gerot;Difenilhidantoina;Fenytoin Dak;Didan TDC 250;Dilantin-125;Epdantoin Simple;Phenytoin AWD;Epilan D;5,5-Diphenyl-2,4-imidazolidinedione;Diphenat;Hindatal;Hydantin;Epanutin;Fenitoina [INN-Spanish];Phenytoine [INN-French];Phenytoinum [INN-Latin];Difenilhidantoina [Spanish];Diphenylhydantoine [French];5,5-Dwufenylohydantoina;Antisacer;Fenantoin Mn Pharma;Diphenylhydantoine;Di-Lan (VAN);PHENYTOIN SODIUM;Diphenylhydantoin (VAN);Diphentoin;DILANTIN-30;Solantoin;Solantyl;Eptoin;DPH (VAN);5,5-diphenyl hydantoin;5,5-Diphenylimidazolidin-2,4-dione;5,5-Diphenyl-imidazolidine-2,4-dione;5,5-Diphenylhydantoin (IUPAC);5,5-Dwufenylohydantoina [Polish];Hydantoin, 5,5-diphenyl-;CCRIS 515;CHEBI:8107;NCI-C55765;5,5-Diphenylhydantoin (phenytoin);AI3-52498;NSC-8722;Dilantin (TN);Novophenytoin;MFCD00005264;MLS000069789;Citrulliamon;DTXSID8020541;Phenitoin;5,5-diphenyltetrahydro-1H-2,4-imidazoledione;Fenidantoin s;NSC8722;SM-88 COMPONENT PHENYTOIN;6158TKW0C5;Epasmir 5;NCGC00021139-03;SMR000059026;Fenidantoin "s";5,5-DIPHENYLHYDANTOIN-D5 98 ATOM % D;DTXCID60541;Epasmir "5";Didan-tdc-250;CAS-57-41-0;phenytoin (PHN);component of Mebroin;fenidantoin ''s'';epasmir ''5'';NSC 8722;EINECS 200-328-6;UNII-6158TKW0C5;SR-01000075211;IFLab1_000214;Fenidantoin 's';HSDB 3160;Episar (Salt/Mix);Epasmir '5';Aladdin (Salt/Mix);Alepsin (Salt/Mix);Epsolin (Salt/Mix);Phenytoin (Lepitoin);Tacosal (Salt/Mix);Phenytoin [USAN:USP:INN:BAN:JAN];Antisacer (Salt/Mix);Epdantoin (Salt/Mix);Epileptin (Salt/Mix);Hydantoin,5-diphenyl-;Spectrum_001105;Fenigramon (Salt/Mix);Citrullamon (Salt/Mix);Opera_ID_394;PHENYTOIN [INN];PHENYTOIN [JAN];2, 5,5-diphenyl-;PHENYTOIN [MI];CHEMBL16;PHENYTOIN [HSDB];PHENYTOIN [IARC];PHENYTOIN [USAN];Spectrum2_001281;Spectrum3_000890;Spectrum4_000984;Spectrum5_001369;Lopac-D-4007;PHENYTOIN [VANDF];Epitope ID:117723;PHENYTOIN [MART.];D 4007;PHENYTOIN [USP-RS];PHENYTOIN [WHO-DD];PHENYTOIN [WHO-IP];SCHEMBL3440;BIDD:PXR0090;Lopac0_000329;Lopac0_000378;Oprea1_373280;BSPBio_001437;KBioGR_001387;KBioSS_001585;MLS001074087;MLS002454401;BIDD:GT0625;DivK1c_000507;Soluble phenytoin (Salt/Mix);SPBio_001281;Phenytoin (JP18/USP/INN);Phenytoin, 1mg/ml in Methanol;GTPL2624;PHENYTOIN [ORANGE BOOK];2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one;PHENYTOIN [EP MONOGRAPH];PHENYTOIN [USP IMPURITY];KBio1_000507;KBio2_001585;KBio2_004153;KBio2_006721;KBio3_001780;PHENYTOIN [USP MONOGRAPH];WLN: T5MVMV EHJ ER& ER;5,5-Diphenylhydantoin, >=99%;NINDS_000507;Phenytoin 1.0 mg/ml in Methanol;HMS1412J16;HMS1694O05;HMS1791H19;HMS1989H19;HMS2089E11;HMS2236J06;HMS3261K17;HMS3402H19;HMS3657O03;PHENYTOINUM [WHO-IP LATIN];BCP05960;HY-B0448;Hydantoin, 5,5-diphenyl- (8CI);Tox21_110861;Tox21_202299;Tox21_300281;Tox21_500378;AC-376;BDBM50003655;BDBM50101816;s2525;STK058029;STK182871;STL454130;AKOS000416887;AKOS003245432;Tox21_110861_1;CCG-104011;CCG-221682;DB00252;LP00378;Phenytoin 1000 microg/mL in Methanol;5,5-di(phenyl)imidazolidine-2,4-dione;IDI1_000507;IDI1_008433;NCGC00015342-01;NCGC00015342-02;NCGC00015342-03;NCGC00015342-04;NCGC00015342-05;NCGC00015342-06;NCGC00015342-07;NCGC00015342-08;NCGC00015342-09;NCGC00015342-10;NCGC00015342-11;NCGC00015342-12;NCGC00021139-01;NCGC00021139-02;NCGC00021139-04;NCGC00021139-05;NCGC00021139-06;NCGC00021139-07;NCGC00021139-08;NCGC00021139-09;NCGC00021139-10;NCGC00021139-11;NCGC00091492-01;NCGC00091492-02;NCGC00091492-03;NCGC00091492-04;NCGC00091492-05;NCGC00093810-01;NCGC00093810-02;NCGC00254135-01;NCGC00259848-01;NCGC00261063-01;5,5-?Diphenyl-?2,4-?imidazolidinedione;DA-56808;imidazolidine-2,4-dione, 5,5-diphenyl-;5,5-Diphenyl-1H-imidazolidine-2,4-dione;D0894;EU-0100378;NS00010290;SW203757-2;EN300-16818;5,5-diphenylimidazolidine-2,4-dione;Phenytoin;C07443;D00512;E76094;2,4-Imidazolidinedione, 5,5-diphenyl- (9CI);AB00374253-10;AB00374253-11;AB00374253_13;A831435;Q410400;SR-01000003141;SR-01000003141-8;SR-01000075211-2;W-105468;BRD-K55930204-001-02-7;BRD-K55930204-001-20-9;BRD-K55930204-236-11-0;BRD-K55930204-236-23-5;BRD-K55930204-236-24-3;Z56786458;4-hydroxy-5,5-diphenyl-1,5-dihydro-2H-imidazol-2-one;F0020-1370;Phenytoin, European Pharmacopoeia (EP) Reference Standard;Phenytoin, United States Pharmacopeia (USP) Reference Standard;Phenytoin, Pharmaceutical Secondary Standard; Certified Reference Material;Phenytoin for system suitability, European Pharmacopoeia (EP) Reference Standard;InChI=1/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19;
InChI
InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)